Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias.

Frontiers in immunology·2018
Same author

NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia.

Trends in immunology·2018
Same author

Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL.

Blood·2018
Same author

Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma.

Cancer research·2018
Same author

Foxm1 controls a pro-stemness microRNA network in neural stem cells.

Scientific reports·2018
Same author

Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML.

Leukemia·2018

Related Experiment Video

Updated: Jun 19, 2026

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

Mesenchymal stromal cells.

Maria Ester Bernardo1, Franco Locatelli, Willem E Fibbe

  • 1Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.

Annals of the New York Academy of Sciences
|October 3, 2009
PubMed
Summary

Mesenchymal stromal cells (MSCs) are potent regenerative cells with immunomodulatory properties. Research highlights their potential in treating immune diseases and aiding tissue repair, advancing cell therapy applications.

Area of Science:

  • Cell Biology
  • Immunology
  • Regenerative Medicine

Background:

  • Mesenchymal stromal cells (MSCs) are multipotent cells found in various human tissues, characterized by adherence, immunophenotype, and differentiation capacity.
  • MSCs exhibit significant immunomodulatory, anti-inflammatory, and tissue repair properties, demonstrated in vitro, in vivo animal models, and human studies.
  • The precise mechanisms of MSC immunomodulation are still under investigation, despite their known therapeutic potential.

Purpose of the Study:

  • To review recent advancements in understanding the biological and functional characteristics of MSCs.
  • To explore the optimization of MSC-based approaches for regenerative cell therapy.
  • To discuss the potential of MSCs in modulating immune responses against alloantigens and autoantigens.

Main Methods:

More Related Videos

Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
10:50

Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats

Published on: April 7, 2023

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

Related Experiment Videos

Last Updated: Jun 19, 2026

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
10:50

Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats

Published on: April 7, 2023

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

  • Literature review of recent scientific publications on Mesenchymal Stromal Cells.
  • Analysis of in vitro and in vivo studies detailing MSC properties and mechanisms.
  • Examination of clinical trial data and case studies involving MSC applications.

Main Results:

  • MSCs demonstrate preferential homing to damaged tissues and secrete paracrine factors with anti-inflammatory effects.
  • Extensive research validates the immunomodulatory, reparative, and anti-inflammatory functions of MSCs across various models.
  • Clinical applications are being explored for graft-versus-host disease, transplant rejection, tissue repair, and autoimmune disorders.

Conclusions:

  • MSCs possess significant therapeutic potential due to their unique biological and functional properties.
  • Ongoing research is refining MSC-based regenerative therapies and immune modulation strategies.
  • MSCs represent a promising avenue for treating a range of immune-mediated and degenerative conditions.